Skip to main content

Table 1 Cardiac differentiation protocols

From: Toward the realization of cardiac regenerative medicine using pluripotent stem cells

Publication

Differentiation method

Media

Coating matrix

Mesoderm induction

Cardiac specification

Differentiation efficiency

Kehat et al. [4]

EB formation

KO DMEM + 20%FBS

Gelatin

NA

NA

8.1% beating EBs

Laflamme et al. [5]

Monolayer

RPMI1640 + B27

Matrigel

Activin A, BMP4

NA

> 30%β-MHC(+)CMs

Yang et al. [6]

EB formation

Stempro34

Gelatin

Activin A, BMP4, bFGF

VEGF, DKK1, bFGF

40–50% TNNT(+)CMs

Tran et al. [7]

EB formation

KO DMEM + 15%FBS

Gelatin

WNT3A

NA

EB formation 10-folds increase (vs control)

Elliot et al. [8]

EB formation or monolayer

LI-APEL

Matrigel

Activin A, BMP4, bFGF, VEGF, SCF, WNT3A

NA

EB:38% Nkx2.5(+) cells

Monolayer:24% Nkx2.5(+) cells

Kattman et al. [9]

EB formation

Stempro34

NA

Activin A, BMP4, bFGF

VEGF, DKK1, TGFβi, BMPi

> 60% TNNT(+)CMs

Zhang et al. [10]

Monolayer

RPMI1640 + B27

Gelatin

Activin A, BMP4, bFGF

NOGGIN, RA/RAi, DKK1

RA:50.7% ± 1.7%

RAi:64.7% ± 0.9%

Willems et al. [11]

EB formation

Stempro34

Gelatin

Activin A, BMP4, bFGF

bFGF,

IWR-1, triiodothyronine

30%MYH6(+)CMs

Zhang et al. [12]

Monolayer (matrix sandwich)

RPMI1640 + B27 insulin(−)

Matrigel

Activin A, BMP4, bFGF

NA

40–92% TNNT(+)CMs

Lian et al. [13]

Monolayer

RPMI1640B27 insulin(−)

Matrigel or Synthemax

CHIR99021

IWP2

85%TNNT(+)CMs

Burridge et al. [14]

Monolayer

CDM3

Vitronectin

CHIR99021

Wnt-C59

80–95% TNNT(+)CMs

Devalla et al. [15]

EB formation

BPEL

Gelatin

Activin A, BMP4, CHIR99021, SCF, VEGF

RA

50%Nkx2.5(+)cells

Protze et al. [16]

EB formation

Stempro34

NA

Activin A, BMP4, bFGF

IWP2, VEGF, BMP4, RA, bFGFi, TGFβi

5%Nkx2.5(+)cells

55%Nkx2.5(−)SANLPCs

Tohyama et al. [17]

Monolayer (multilayer plates)

RPMI1640 + B27 insulin(−)

Fibronectin or type1 collagen

CHIR99021, BMP4

IWR-1

80%TNNT(+)CMs

  1. Modified table taken from [18]
  2. Abbreviations: bFGF basic fibroblast growth factor, bFGFi bFGF inhibitor, BMP bone morphologic protein, BMPi BMP inhibitor, CMs cardiomyocytes, DKK Dickkopf, DMSO dimethyl sulfoxide, EB embryoid body, FBS fetal bovine serum, KO knockout, MLC myosin light chain, N/A not applicable or not available, TGFβ transforming growth factor β, TGFβi TGFβ inhibitor, TNNT troponin T, SALPC sinoatrial node-like progenitor cells, SCF stem cell factor, VEGF vascular endothelial growth factor